DNA methylation profile in patients with indolent systemic mastocytosis
Abstract Background Mastocytosis is a clinically heterogeneous, usually acquired disease of the mast cells with a survival time that depends on the onset of the disease and ranges from skin‐limited to systemic disease, including indolent and more aggressive variants. The crucial element in pathogene...
Guardado en:
Autores principales: | Aleksandra Górska, Ewa Jabłońska, Edyta Reszka, Marek Niedoszytko, Magdalena Lange, Marta Gruchała‐Niedoszytko, Justyna Jarczak, Dominik Strapagiel, Magdalena Górska‐Ponikowska, Paulina Bastian, Iwona Pelikant‐Małecka, Leszek Kalinowski, Bogusław Nedoszytko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5dfa142e2b0b4c2caf9ca17b00a8a9ea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel approaches to treating advanced systemic mastocytosis
por: Gilreath JA, et al.
Publicado: (2019) -
Precision Medicine in Systemic Mastocytosis
por: Maura Nicolosi, et al.
Publicado: (2021) -
Morphological Features and KIT Receptor Expression in Canine Cutaneous Mast Cell Tumor and Systemic Mastocytosis / Morfološke Karakteristike I Ekspresija KIT Receptora Kod Kutanih Mastocitoma I Sistemske Mastocitoze Pasa
por: Marinković Darko, et al.
Publicado: (2015) -
Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib
por: Mariarita Sciumè, et al.
Publicado: (2021) -
Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma
por: Philipp Tschandl, et al.
Publicado: (2012)